Carlisle Regional Cancer Center — Carlisle, Pennsylvania

Carlisle Regional Cancer Center is a clinical research site located in Carlisle, Pennsylvania, United States 17015.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Carlisle Regional Cancer Center has participated in 48 clinical trials with 46 currently active.

Therapeutic areas: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carlisle Regional Cancer Center?

Carlisle Regional Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carlisle Regional Cancer Center conducted?

Carlisle Regional Cancer Center has 48 clinical trials on record, with 46 currently active. Their work covers Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Is Carlisle Regional Cancer Center accredited by Crixeo Health?

Yes — Carlisle Regional Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Carlisle Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.